flurbiprofen has been researched along with Cancer of Stomach in 4 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Less morphine was consumed and the time of first flatus was earlier in patients receiving morphine with flurbiprofen than morphine alone." | 2.79 | Flurbiprofen improves dysfunction of T-lymphocyte subsets and natural killer cells in cancer patients receiving post-operative morphine analgesia. ( Liu, XY; Shen, JC; Sun, HL; Wang, Z; Yang, JJ; Zhang, MQ, 2014) |
| "Nevertheless, when gastric cancer cells were treated with different NSAIDs, the non-Cox-2-inhibiting R-flurbiprofen was most effective at reducing proliferation of gastric cancer cells in vitro." | 1.36 | R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction. ( Fan, D; Gao, L; Hong, L; Jin, H; Li, X; Liang, J; Liu, L; Liu, N; Pan, Y; Shi, H; Sun, L; Wang, Z; Wu, K; Wu, Q; Yang, Z; Zhao, H, 2010) |
| "The first squamous cell carcinomas of the forestomach were detected on day 51." | 1.27 | Effect of flurbiprofen and 16,16-dimethyl-prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue. ( DeCosse, JJ; Deschner, EE; Karmali, RA; Lehnert, T, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, JC | 1 |
| Sun, HL | 1 |
| Zhang, MQ | 1 |
| Liu, XY | 1 |
| Wang, Z | 2 |
| Yang, JJ | 1 |
| Jin, H | 1 |
| Liu, L | 1 |
| Gao, L | 1 |
| Sun, L | 1 |
| Li, X | 1 |
| Zhao, H | 1 |
| Pan, Y | 1 |
| Shi, H | 1 |
| Liu, N | 1 |
| Hong, L | 1 |
| Liang, J | 1 |
| Wu, Q | 1 |
| Yang, Z | 1 |
| Wu, K | 1 |
| Fan, D | 1 |
| Lehnert, T | 2 |
| Deschner, EE | 2 |
| Karmali, RA | 2 |
| DeCosse, JJ | 2 |
1 trial available for flurbiprofen and Cancer of Stomach
| Article | Year |
|---|---|
Flurbiprofen improves dysfunction of T-lymphocyte subsets and natural killer cells in cancer patients receiving post-operative morphine analgesia.
Topics: Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroi | 2014 |
3 other studies available for flurbiprofen and Cancer of Stomach
| Article | Year |
|---|---|
R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Base Sequence; C | 2010 |
Effect of flurbiprofen and 16,16-dimethyl prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats: glandular epithelium of stomach and duodenum.
Topics: 16,16-Dimethylprostaglandin E2; Adenocarcinoma; Animals; Body Weight; Duodenal Neoplasms; Female; Fl | 1990 |
Effect of flurbiprofen and 16,16-dimethyl-prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue.
Topics: Animals; Body Weight; Carcinoma, Squamous Cell; Female; Flurbiprofen; Gastric Acid; Gastrointestinal | 1987 |